| Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening E Quintero, A Castells, L Bujanda, J Cubiella, D Salas, Á Lanas, ... New England Journal of Medicine 366 (8), 697-706, 2012 | 1186 | 2012 |
| Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn … J Panes, R Bouzas, M Chaparro, V García‐Sánchez, JP Gisbert, ... Alimentary pharmacology & therapeutics 34 (2), 125-145, 2011 | 808 | 2011 |
| ECCO guidelines on therapeutics in ulcerative colitis: medical treatment T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16 (1), 2-17, 2022 | 738 | 2022 |
| ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14 (2), 155-168, 2020 | 595 | 2020 |
| Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis DS Kotlyar, JD Lewis, L Beaugerie, A Tierney, CM Brensinger, JP Gisbert, ... Clinical Gastroenterology and Hepatology 13 (5), 847-858. e4, 2015 | 442 | 2015 |
| Systematic review with meta‐analysis: the efficacy of a second anti‐TNF in patients with inflammatory bowel disease whose previous anti‐TNF treatment has failed JP Gisbert, AC Marín, AG McNicholl, M Chaparro Alimentary pharmacology & therapeutics 41 (7), 613-623, 2015 | 352 | 2015 |
| Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients M Chaparro, I Ordás, E Cabré, V Garcia-Sanchez, G Bastida, M Peñalva, ... Inflammatory bowel diseases 19 (7), 1404-1410, 2013 | 349 | 2013 |
| Systematic review with meta‐analysis: the declining risk of colorectal cancer in ulcerative colitis C Castaño‐Milla, M Chaparro, JP Gisbert Alimentary pharmacology & therapeutics 39 (7), 645-659, 2014 | 327 | 2014 |
| Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease MJ Casanova, M Chaparro, E Domenech, M Barreiro-de Acosta, ... Official journal of the American College of Gastroenterology| ACG 108 (3 …, 2013 | 265 | 2013 |
| Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice JP Gisbert, M Chaparro Journal of Crohn's and Colitis 14 (5), 694-709, 2020 | 239 | 2020 |
| The risk of relapse after anti-TNF discontinuation in inflammatory bowel disease: systematic review and meta-analysis JP Gisbert, AC Marin, M Chaparro Official journal of the American College of Gastroenterology| ACG 111 (5 …, 2016 | 221 | 2016 |
| Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease MJ Casanova, M Chaparro, B Molina, O Merino, R Batanero, ... Journal of Crohn's and Colitis 11 (12), 1430-1439, 2017 | 218 | 2017 |
| Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy C Loras, JP Gisbert, M Mínguez, O Merino, L Bujanda, C Saro, ... Gut 59 (10), 1340-1346, 2010 | 214 | 2010 |
| Systematic review with meta‐analysis: inflammatory bowel disease in the elderly JP Gisbert, M Chaparro Alimentary pharmacology & therapeutics 39 (5), 459-477, 2014 | 212 | 2014 |
| Microbiota sensing by Mincle-Syk axis in dendritic cells regulates interleukin-17 and-22 production and promotes intestinal barrier integrity M Martinez-Lopez, S Iborra, R Conde-Garrosa, A Mastrangelo, C Danne, ... Immunity 50 (2), 446-461. e9, 2019 | 204 | 2019 |
| Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 197 | 2018 |
| Ustekinumab for the treatment of refractory Crohn's disease: the Spanish experience in a large multicentre open-label cohort S Khorrami, D Ginard, I Marín-Jiménez, M Chaparro, M Sierra, M Aguas, ... Inflammatory bowel diseases 22 (7), 1662-1669, 2016 | 191 | 2016 |
| ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment A Spinelli, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16 (2), 179-189, 2022 | 187 | 2022 |
| Systematic review: antibodies and anti‐TNF‐α levels in inflammatory bowel disease M Chaparro, I Guerra, P Muñoz‐Linares, JP Gisbert Alimentary pharmacology & therapeutics 35 (9), 971-986, 2012 | 183 | 2012 |
| Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study) MA Montoro, LJ Brandt, S Santolaria, F Gomollon, BS Puértolas, J Vera, ... Scandinavian journal of gastroenterology 46 (2), 236-246, 2011 | 181 | 2011 |
